Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandprotese Klinikken Kalundborg ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   4.0% 2.8% 1.6% 1.3% 5.8% 2.5% 10.4% 10.4%   Credit score (0-100)   51 60 74 78 39 61 24 24   Credit rating   BBB BBB A A BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 3.0 29.1 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,564 1,922 2,389 3,259 2,337 2,544 0.0 0.0   EBITDA   65.3 126 375 954 -427 190 0.0 0.0   EBIT   41.2 88.6 258 876 -501 134 0.0 0.0   Pre-tax profit (PTP)   37.5 83.4 244.6 866.9 -522.6 118.3 0.0 0.0   Net earnings   28.3 63.4 190.2 673.2 -502.9 118.3 0.0 0.0   Pre-tax profit without non-rec. items   37.5 83.4 245 867 -523 118 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   54.2 376 349 452 345 288 0.0 0.0   Shareholders equity total   416 480 670 1,230 727 846 796 796   Interest-bearing liabilities   41.7 281 229 163 0.8 0.6 0.0 0.0   Balance sheet total (assets)   663 1,470 1,568 2,056 1,713 1,483 796 796   Net Debt   -159 -305 -653 -786 -697 -186 -796 -796     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,564 1,922 2,389 3,259 2,337 2,544 0.0 0.0   Gross profit growth   -16.3% 22.9% 24.3% 36.4% -28.3% 8.8% -100.0% 0.0%   Employees   3 3 3 4 5 4 0 0   Employee growth %   0.0% 0.0% 0.0% 33.3% 25.0% -20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   663 1,470 1,568 2,056 1,713 1,483 796 796   Balance sheet change%   -9.3% 121.7% 6.7% 31.1% -16.7% -13.4% -46.4% 0.0%   Added value   65.3 125.8 374.5 953.5 -423.6 190.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -48 284 -143 25 -181 -114 -288 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.6% 4.6% 10.8% 26.9% -21.5% 5.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.9% 8.3% 17.0% 48.6% -26.6% 8.4% 0.0% 0.0%   ROI %   9.6% 13.9% 28.9% 73.8% -46.8% 17.0% 0.0% 0.0%   ROE %   7.0% 14.1% 33.1% 70.9% -51.4% 15.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   62.8% 32.6% 42.7% 59.9% 42.5% 57.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -243.2% -242.7% -174.4% -82.4% 163.2% -97.5% 0.0% 0.0%   Gearing %   10.0% 58.7% 34.2% 13.2% 0.1% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   17.6% 3.2% 5.2% 6.6% 25.8% 2,315.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.2 1.3 1.4 1.9 1.4 1.8 0.0 0.0   Current Ratio   2.3 1.3 1.4 2.0 1.4 1.8 0.0 0.0   Cash and cash equivalent   200.6 586.6 882.0 948.6 698.1 186.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   320.7 260.1 362.9 766.8 412.4 526.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   22 42 125 238 -85 48 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   22 42 125 238 -85 48 0 0   EBIT / employee   14 30 86 219 -100 33 0 0   Net earnings / employee   9 21 63 168 -101 30 0 0